Design of a Novel Integration-deficient Lentivector Technology That Incorporates Genetic and Posttranslational Elements to Target Human Dendritic CellsSemih U. Tareen, Scott H. Robbins, Christopher J. Nicolai et al.|Molecular Therapy|2013Cited by 32